| Generic name | 6-Thioguanine |
| Pronunciation | siks-thy-oh-GWAH-neen |
| Brand name(s), other common name(s) | Tabloid®, thioguanine |
| Drug type | Antimetabolite |
| How the drug is given | By mouth |
Indications and Usage
6-Thioguanine is FDA approved for remission induction and remission consolidation treatment of acute nonlymphocytic leukemias.
Side effects needing medical attention
Fever; chills; sore throat; unusual bruising or bleeding; sores on mouth or lips; yellowing of skin or eyes; inability to eat; loose stools; stomach pain; rash; nausea and vomiting.
Side effects needing medical attention after stopping this medication
Black, tarry stools; blood in urine or stools; cough or hoarseness; fever or chills; lower back or side pain; painful or difficult urination; pinhead-sized red spots on skin; unusual bleeding or bruising.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.